Marvin Ilacas De los Santos

Home About Us

Archive

Samuel Bernal 1 protocol

Marvin Ilacas De los Santos

Senior Research Scientist, Globetek Science Foundation

Research focus

Immunology
Cancer Biology
Biological Therapeutics
Cellular Therapy
Immune Engineering
T cell biology
Molecular Immunology
Autoimmune Disease
Immunotherapy

1 Author merit
Reviewer merit
Editor merit

Lab information

https://globetekscientific.wixsite.com/home

Publications

http://systems.enpress-publisher.com/index.php/ti/article/view/1064/826

CAR-T Therapy for Solid Tumors: Development of New Strategies (Trends in Immunotherapy)

1 Protocol published

Cellular Retention Assay to Determine the Interaction Frequency of CD19-directed Chimeric Antigen Receptor (CAR) Engineered Cells against CD19⁺ Leukemic Cells

Authors: Marvin I. De los Santos and Samuel D. Bernal, date: 09/05/2019, view: 815, Q&A: 0

Cancer recognition by chimeric antigen receptor T (CAR-T) cell is prerequisite for cancer killing to occur. Anomalies in the binding specificity of scFv in the CAR construct may prevent successful eradication of these cancer cells. In some cases, ...

More >